Public Health Through Community Strategies for Maintaining Musculoskeletal Function in Aging Populations

Abstract

The preservation of musculoskeletal function in aging populations represents a cornerstone of public health, directly influencing independence, quality of life, and healthcare resource utilization. This review synthesizes current evidence on epidemiology, pathophysiology, risk factors, clinical features, diagnosis, management, and recent advances, with particular emphasis on community-based strategies. The discussion integrates guideline-directed recommendations and explores mechanisms by which targeted interventions can mitigate age-related musculoskeletal decline, providing actionable insights for clinicians and public health practitioners.

Introduction

Musculoskeletal health is a determinant of mobility, autonomy, and overall well-being in older adults. As global populations age, the incidence and impact of musculoskeletal disorders such as sarcopenia, osteoporosis, and osteoarthritis are projected to rise, presenting significant clinical and societal challenges. Effective public health strategies, particularly those rooted in community engagement, are vital for maintaining musculoskeletal function and reducing associated morbidity and healthcare costs. This article reviews the current scientific landscape, focusing on the pathogenesis of musculoskeletal decline, risk stratification, and the implementation of evidence-based community interventions.

Epidemiology / Disease Burden

The global prevalence of musculoskeletal disorders in older adults is substantial, with the World Health Organization estimating that up to 30% of individuals over 60 years experience significant functional impairment. Osteoarthritis affects over 250 million people worldwide, while osteoporosis leads to more than 8.9 million fractures annually. Sarcopenia prevalence increases with age, impacting up to 50% of those over 80. These conditions contribute to increased falls, hospitalizations, long-term care admissions, and mortality, underscoring the need for robust public health interventions. Community-based programs have demonstrated efficacy in reducing the incidence of falls and frailty, further highlighting their importance in disease burden mitigation.

Pathophysiology

Age-related musculoskeletal decline involves multifactorial mechanisms. Sarcopenia is characterized by progressive loss of skeletal muscle mass and function due to a combination of neuromuscular degeneration, hormonal alterations, chronic inflammation, and decreased physical activity. Osteoporosis arises from imbalances in bone remodeling, favoring resorption over formation, often exacerbated by estrogen deficiency, vitamin D insufficiency, and secondary hyperparathyroidism. Osteoarthritis results from mechanical stress, cartilage degeneration, and subchondral bone remodeling. Systemic factors such as oxidative stress, mitochondrial dysfunction, and chronic low-grade inflammation (inflammaging) further contribute to tissue degeneration, highlighting potential therapeutic targets.

Risk Factors

Modifiable and non-modifiable factors contribute to musculoskeletal decline in aging. Age and genetics are primary non-modifiable risks, whereas lifestyle factors including physical inactivity, inadequate nutrition (particularly protein and calcium intake), smoking, and excessive alcohol consumption are modifiable. Comorbidities such as diabetes, obesity, and chronic kidney disease exacerbate risk. Social determinants, including isolation, limited access to safe environments for activity, and socioeconomic status, also significantly influence musculoskeletal health, supporting the rationale for community-focused interventions.

Clinical Features

Sarcopenia presents with progressive muscle weakness, reduced endurance, and impaired physical performance, often manifesting as difficulty rising from a chair or climbing stairs. Osteoporosis typically remains asymptomatic until a fracture occurs, frequently affecting the hip, vertebrae, or wrist. Osteoarthritis is characterized by joint pain, stiffness, swelling, and reduced mobility. These disorders often coexist, compounding functional impairment, fall risk, and loss of independence, with substantial psychosocial and economic repercussions.

Diagnosis

Early detection is critical to prevent irreversible disability. Sarcopenia is diagnosed using criteria from the European Working Group on Sarcopenia in Older People (EWGSOP), integrating muscle mass assessment (e.g., dual-energy X-ray absorptiometry), grip strength, and physical performance tests (e.g., gait speed, chair stand). Osteoporosis is defined by bone mineral density (BMD) measurement using DXA, with a T-score ≤–2.5. Clinical risk assessment tools, such as FRAX, guide fracture risk stratification. Osteoarthritis diagnosis is generally clinical, supported by imaging when necessary. Population screening in high-risk groups and community settings improves early identification and intervention.

Treatment & Management

Management is multidisciplinary, emphasizing both pharmacologic and non-pharmacologic approaches. Resistance and balance training are central to sarcopenia and fall prevention, with evidence supporting supervised group exercise programs in community centers. Adequate protein, vitamin D, and calcium intake are vital. Osteoporosis management includes bisphosphonates, denosumab, and selective estrogen receptor modulators, alongside lifestyle modification. Osteoarthritis is managed through weight loss, physical therapy, analgesics, and, when indicated, intra-articular therapies. Community-based interventions such as fall prevention classes, nutrition workshops, and home hazard assessments have demonstrated efficacy in improving outcomes and reducing healthcare utilization.

Recent Advances / Emerging Therapies

Recent advances include the development of myostatin inhibitors and selective androgen receptor modulators for sarcopenia, and anabolic agents such as romosozumab for osteoporosis. Digital health platforms and tele-rehabilitation are emerging as scalable solutions for exercise prescription and adherence monitoring in older adults. Wearable technologies enable real-time assessment of mobility and fall risk, facilitating personalized interventions. Community strategies increasingly leverage social prescribing and peer-support networks to enhance engagement and sustainability.

Guideline Recommendations

Major organizations recommend routine assessment of musculoskeletal function in adults over 65, including mobility screening, falls risk evaluation, and osteoporosis risk stratification. The American Geriatrics Society and International Osteoporosis Foundation advocate for community-based exercise and multifactorial fall prevention programs. Nutritional optimization and environmental modifications are emphasized. Implementation of these guidelines at the community level, through primary care integration and public health campaigns, is crucial for effective population health management.

Conclusion

Maintaining musculoskeletal function in aging populations is of paramount importance for individual and public health. Community strategies encompassing exercise, nutrition, education, and environmental modification are central to prevention and management. Recent advances in pharmacotherapy and digital health complement traditional interventions. Adoption of guideline-directed, community-based approaches offers a practical and effective means to reduce disease burden, enhance quality of life, and promote healthy aging. Ongoing research and public health policy must prioritize accessible, evidence-based musculoskeletal care for the aging demographic.